Literature DB >> 32877708

Should Patients With Inflammatory Bowel Disease Be Tested for Active COVID-19 Before Starting a Biological Treatment?

Brigida Barberio1, Andrea Buda2, Edoardo Vincenzo Savarino1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32877708      PMCID： PMC7456452          DOI： 10.1053/j.gastro.2020.08.049

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  5 in total

Review 1.  Latest insights into the hot question of proton pump inhibitor safety - a narrative review.

Authors:  Vincenzo Savarino; Elisa Marabotto; Manuele Furnari; Fabiana Zingone; Patrizia Zentilin; Edoardo Savarino
Journal:  Dig Liver Dis       Date:  2020-06-06       Impact factor: 4.088

2.  Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study.

Authors:  Cristina Bezzio; Simone Saibeni; Angela Variola; Mariangela Allocca; Alessandro Massari; Viviana Gerardi; Valentina Casini; Chiara Ricci; Fabiana Zingone; Arnaldo Amato; Flavio Caprioli; Marco Vincenzo Lenti; Chiara Viganò; Marta Ascolani; Fabrizio Bossa; Fabiana Castiglione; Claudio Cortelezzi; Laurino Grossi; Monica Milla; Daniela Morganti; Luca Pastorelli; Davide Giuseppe Ribaldone; Alessandro Sartini; Alessandra Soriano; Gianpiero Manes; Silvio Danese; Massimo Claudio Fantini; Alessandro Armuzzi; Marco Daperno; Gionata Fiorino
Journal:  Gut       Date:  2020-04-30       Impact factor: 23.059

3.  Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease.

Authors:  Dana J Lukin; Anand Kumar; Kaveh Hajifathalian; Reem Z Sharaiha; Ellen J Scherl; Randy S Longman
Journal:  Gastroenterology       Date:  2020-05-29       Impact factor: 22.682

4.  Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak.

Authors:  Fabiana Zingone; Edoardo Vincenzo Savarino
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-03-25

5.  AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.

Authors:  David T Rubin; Joseph D Feuerstein; Andrew Y Wang; Russell D Cohen
Journal:  Gastroenterology       Date:  2020-04-10       Impact factor: 22.682
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.